Motley Fool
Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now
Regencell Bioscience doesn't have a product yet, and there's no indication that one is on the way.
Read sourceEQUITYNCMUSDHealthcareDrug Manufacturers - Specialty & Generic
RGC
Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Day range
$29.50 - $37.99
52W range
$0.62 - $83.60
Market cap
$15.23B
Dividend yield
Unavailable
Current price
$30.80
-2.71 (-8.09%)
Previous close$33.51
Open$32.06
Volume328,900
Avg volume234,040
Trailing PEUnavailable
Forward PEUnavailable
Analyst targetUnavailable
Company website
Data limitations
- Earnings date is unavailable from the data provider.
Price chart
Chart
$30.80 latest close
Last close
$30.80
Open
$32.06
Volume
328,900
Bars
125
Research
Financials, earnings, analyst sentiment, ownership, and options data.
Summary
TTM and capital structure
Loading…
Trend
Annual and quarterly revenue
Loading…